CompletedNCT06221176
Anxiety biomarker study for autism assessment
About this title
Read the official source — NCT06221176Behavioural studyAges 3–6United States
Understand this study
Who was this study for?
Listed age limits: 3 years to 6 years.
- Listed locations
- BrooklineSee all locations and recruitment
Study information
Study start dateStarted: April 2, 2024
- Recruitment status
- Completed
- Enrollment listed in the registry
- 30
- Sponsor
- Boston Children's Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Behavioral
- Intervention type
- Psychotherapy / behavioral intervention
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- From 3 Years to 6 Years
- Official registry ID
- NCT06221176
- Official title
Show the full official title
Translational Biomarkers and Therapeutic Development for Very Young Children Diagnosed With Autism Spectrum Disorder and Co-occurring Anxiety
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Brookline
Questions about this study
Who is behind this study?
The study sponsor is Boston Children's Hospital, a hospital or academic medical center.
Who was this study for?
Listed age limits: 3 years to 6 years.
